Bempikibart (ADX-914) is under development for the treatment of atopic dermatitis and alopecia areata. It is administered through subcutaneous route and acts by targeting interleukin-7 receptor (IL-7R ...

ENB-105 is under development for the treatment of inflammatory bowel disease and immune checkpoint inhibitor colitis (ICI-Colitis). It is being developed based on eSTEM systems biology platform.

VANCOUVER, British Columbia, Dec. 31, 2024 (GLOBE NEWSWIRE) -- VERSES AI Inc. (CBOE:VERS) (OTCQB:VRSSF) ("VERSES'' or the ...

Bloomberg Green looks at how energy markets, consumer spending and diplomacy will shape the future of the planet this year.

VERSES AI Inc. (CBOE:VERS) (OTCQB:VRSSF) ("VERSES' or the "Company"), a cognitive computing company specializing in next generation intelligent ...

It said the consultation begun today would examine how the 'current arrangements and flexibilities are working,' which hybrid ...

Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors.

The success or failure of this transition hinges on the results of ... the target is “3 percent or higher.” “To ensure a phase change in the domestic economy and society, we will aim for ...

Liverpool’s new manager has openly acknowledged that his playing style is not worlds apart from his predecessor, Jurgen Klopp, which has made the transition from one to the other far smoother.

The war between Russia and Ukraine has now entered its 1044th day since starting on February 24, 2022. In this relatively short time, drones have become a bona fide tour de force on the battlefield.

AVITA Medical's Q3 report showed strong sequential sales growth and a lower burn rate. My confidence in it reaching breakeven ...

As 2024 ends, India’s AI sector has transitioned from its experimentation stage to strategic adoption, primarily driven by ...